Literature DB >> 34177435

Biallelic Mutations in DNAJB11 are Associated with Prenatal Polycystic Kidney Disease in a Turkish Family.

Esra Arslan Ateş1, Ayberk Turkyilmaz2, Kenan Delil3, Ceren Alavanda3, Mehmet Ali Söylemez3, Bilgen Bilge Geçkinli3, Pinar Ata3, Ahmet Arman3.   

Abstract

Polycystic kidney disease (PKD) is a life-threatening condition resulting in end-stage renal disease. Two major forms of PKD are defined according to the inheritance pattern. Autosomal dominant PKD (ADPKD) is characterized by renal cysts, where nearly half of the patients suffers from renal failure in the 7th decade of life. Autosomal recessive PKD (ARPKD) is a rarer and more severe form presenting in childhood. Whole-exome sequencing (WES) analyses was performed to investigate molecular causes of the disease in the fetus. In this study, we present 2 fetuses prenatally diagnosed with PKD in a consanguineous family. WES analysis of the second fetus revealed a homozygous variant (c.740+1G>A) in DNAJB11 which is related to ADPKD. This study reveals that DNAJB11 biallelic mutations may cause an antenatal severe form of ARPKD and contributes to understanding the DNAJB11-related ADPKD phenotype. The possibility of ARPKD due to biallelic mutations in ADPKD genes should be considered in genetic counseling.
Copyright © 2021 by S. Karger AG, Basel.

Entities:  

Keywords:  DNAJB11; Genetic counseling; Nephrology; Polycystic kidney disease; Whole-exome sequencing

Year:  2021        PMID: 34177435      PMCID: PMC8216001          DOI: 10.1159/000513611

Source DB:  PubMed          Journal:  Mol Syndromol        ISSN: 1661-8769


  15 in total

1.  Monoallelic Mutations to DNAJB11 Cause Atypical Autosomal-Dominant Polycystic Kidney Disease.

Authors:  Emilie Cornec-Le Gall; Rory J Olson; Whitney Besse; Christina M Heyer; Vladimir G Gainullin; Jessica M Smith; Marie-Pierre Audrézet; Katharina Hopp; Binu Porath; Beili Shi; Saurabh Baheti; Sarah R Senum; Jennifer Arroyo; Charles D Madsen; Claude Férec; Dominique Joly; François Jouret; Oussamah Fikri-Benbrahim; Christophe Charasse; Jean-Marie Coulibaly; Alan S Yu; Korosh Khalili; York Pei; Stefan Somlo; Yannick Le Meur; Vicente E Torres; Peter C Harris
Journal:  Am J Hum Genet       Date:  2018-04-26       Impact factor: 11.025

2.  Type of PKD1 mutation influences renal outcome in ADPKD.

Authors:  Emilie Cornec-Le Gall; Marie-Pierre Audrézet; Jian-Min Chen; Maryvonne Hourmant; Marie-Pascale Morin; Régine Perrichot; Christophe Charasse; Bassem Whebe; Eric Renaudineau; Philippe Jousset; Marie-Paule Guillodo; Anne Grall-Jezequel; Philippe Saliou; Claude Férec; Yannick Le Meur
Journal:  J Am Soc Nephrol       Date:  2013-02-21       Impact factor: 10.121

3.  Bialleleic PKD1 mutations underlie early-onset autosomal dominant polycystic kidney disease in Saudi Arabian families.

Authors:  Mohamed H Al-Hamed; Nada Alsahan; Sarah J Rice; Noel Edwards; Eman Nooreddeen; Maha Alotaibi; Wesam Kurdi; Maha Alnemer; Naderah Altaleb; Wafa Ali; Nouf Al-Numair; Najd Almejaish; John A Sayer; Faiqa Imtiaz
Journal:  Pediatr Nephrol       Date:  2019-05-11       Impact factor: 3.714

Review 4.  Polycystic kidney disease.

Authors:  Carsten Bergmann; Lisa M Guay-Woodford; Peter C Harris; Shigeo Horie; Dorien J M Peters; Vicente E Torres
Journal:  Nat Rev Dis Primers       Date:  2018-12-06       Impact factor: 52.329

5.  Incompletely penetrant PKD1 alleles mimic the renal manifestations of ARPKD.

Authors:  Mihailo Vujic; Christina M Heyer; Elisabet Ars; Katharina Hopp; Arseni Markoff; Charlotte Orndal; Bengt Rudenhed; Samih H Nasr; Vicente E Torres; Roser Torra; Nadja Bogdanova; Peter C Harris
Journal:  J Am Soc Nephrol       Date:  2010-06-17       Impact factor: 10.121

6.  Systems biology of autosomal dominant polycystic kidney disease (ADPKD): computational identification of gene expression pathways and integrated regulatory networks.

Authors:  Xuewen Song; Valeria Di Giovanni; Ning He; Kairong Wang; Alistair Ingram; Norman D Rosenblum; York Pei
Journal:  Hum Mol Genet       Date:  2009-04-03       Impact factor: 6.150

7.  Clinical spectrum, prognosis and estimated prevalence of DNAJB11-kidney disease.

Authors:  Vinh T Huynh; Marie-Pierre Audrézet; John A Sayer; Albert C Ong; Siriane Lefevre; Valoris Le Brun; Aurore Després; Sarah R Senum; Fouad T Chebib; Miguel Barroso-Gil; Chirag Patel; Andrew J Mallett; Himanshu Goel; Amali C Mallawaarachchi; Albertien M Van Eerde; Eléonore Ponlot; Marc Kribs; Yannick Le Meur; Peter C Harris; Emilie Cornec-Le Gall
Journal:  Kidney Int       Date:  2020-03-23       Impact factor: 10.612

8.  Cerebral Microbleeds in Autosomal Dominant Polycystic Kidney Disease.

Authors:  Li-Kai Tsai; Pei-Lung Chen; Hsin-Hsi Tsai; Ya-Fang Chen; Ping-Chun Wu; Jiann-Shing Jeng; Jenq-Wen Huang; Tzong-Shinn Chu; Juliana Tze-Wah Kao
Journal:  J Stroke       Date:  2020-01-31       Impact factor: 6.967

9.  Bi-allelic pathogenic variations in DNAJB11 cause Ivemark II syndrome, a renal-hepatic-pancreatic dysplasia.

Authors:  Penelope Jordan; Christelle Arrondel; Bettina Bessières; Aude Tessier; Tania Attié-Bitach; Sarah Guterman; Vincent Morinière; Corinne Antignac; Sophie Saunier; Marie-Claire Gubler; Laurence Heidet
Journal:  Kidney Int       Date:  2020-10-28       Impact factor: 10.612

10.  Human Splicing Finder: an online bioinformatics tool to predict splicing signals.

Authors:  François-Olivier Desmet; Dalil Hamroun; Marine Lalande; Gwenaëlle Collod-Béroud; Mireille Claustres; Christophe Béroud
Journal:  Nucleic Acids Res       Date:  2009-04-01       Impact factor: 16.971

View more
  2 in total

1.  Monoallelic IFT140 pathogenic variants are an important cause of the autosomal dominant polycystic kidney-spectrum phenotype.

Authors:  Sarah R Senum; Ying Sabrina M Li; Katherine A Benson; Giancarlo Joli; Eric Olinger; Sravanthi Lavu; Charles D Madsen; Adriana V Gregory; Ruxandra Neatu; Timothy L Kline; Marie-Pierre Audrézet; Patricia Outeda; Cherie B Nau; Esther Meijer; Hamad Ali; Theodore I Steinman; Michal Mrug; Paul J Phelan; Terry J Watnick; Dorien J M Peters; Albert C M Ong; Peter J Conlon; Ronald D Perrone; Emilie Cornec-Le Gall; Marie C Hogan; Vicente E Torres; John A Sayer; Peter C Harris
Journal:  Am J Hum Genet       Date:  2021-12-09       Impact factor: 11.043

2.  More dissimilarities than affinities between DNAJB11-PKD and ADPKD.

Authors:  Isabella Pisani; Marco Allinovi; Viviana Palazzo; Paola Zanelli; Micaela Gentile; Maria Teresa Farina; Sara Giuliotti; Paolo Cravedi; Marco Delsante; Umberto Maggiore; Enrico Fiaccadori; Lucio Manenti
Journal:  Clin Kidney J       Date:  2022-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.